It has also been reported that decreased platelet CXCR4 expression in CAD patients is associated with an increase in cardiovascular events and all-cause mortality, while increased ACKR3 is associated with improved outcomes [101]. This evidence concerns the gene ACKR3 and coronary artery disorder.